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j Abstract The aim of this study
is to assess the efficacy of a
restricted elimination diet in
reducing symptoms in an unse-
lected group of children with
Attention deficit/hyperactivity
disorder (ADHD). Dietary studies
have already shown evidence of
efficacy in selected subgroups.
Twenty-seven children (mean age
6.2) who all met the DSM-IV
criteria for ADHD, were assigned
randomly to either an intervention
group (15/27) or a waiting-list
control group (12/27). Primary
endpoint was the clinical response,
i.e. a decrease in the symptom
scores by 50% or more, at week 9
based on parent and teacher rat-
ings on the abbreviated ten-item
Conners Scale and the ADHD-
DSM-IV Rating Scale. The inten-
tion-to-treat analysis showed that
the number of clinical responders
in the intervention group was
significantly larger than that in the
control group [parent ratings 11/
15 (73%) versus 0/12 (0%); teacher
ratings, 7/10 (70%) versus 0/7
(0%)]. The Number of ADHD
criteria on the ADHD Rating Scale
showed an effect size of 2.1
(cohen’s d) and a scale reduction
of 69.4%. Comorbid symptoms of
oppositional defiant disorder also
showed a significantly greater
decrease in the intervention group
than it did in the control group
(cohens’s d 1.1, scale reduction
45.3%). A strictly supervised
elimination diet may be a valuable
instrument in testing young chil-
dren with ADHD on whether die-
tary factors may contribute to the
manifestation of the disorder and
may have a beneficial effect on the
children’s behaviour.
j Key words ADHD Æ
few foods diet Æ elimination diet Æ
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trial
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Introduction
Attention deficit/hyperactivity disorder (ADHD) is
one of the most common behavioural disorders in
childhood, with symptoms often persisting across
adolescence into adulthood [16]. Long-term risk
outcomes of children with ADHD include under-
achievement at school and antisocial personality dis-
order, delinquency and substance abuse, marital
breakdown and unemployment at adult life [19].
ADHD is a multifactorial disorder in which genetic
risk factors predominate and various other environ-
mental factors may be involved [5, 32]. The exact
aetiological pathways of ADHD, however, are still
unknown [22, 31].
According to current professional guidelines,
medication and psychosocial interventions are the
methods of treatment mostly recommended and most
frequently used [12, 18, 31]. According an expert
opinion, it is important to avoid overreliance on
currently available pharmacological approaches, sug-
gesting that, among others, more research on dietary
effects is essential [29]. There is evidence for the
effectiveness of an individually constructed elimina-
tion diet, the ‘‘few foods’’ approach [15]. Dietary
studies using a few foods diet, i.e. a restricted elimi-
nation diet consisting of a limited number of foods [7,
8, 14, 17, 25, 26], have shown evidence of efficacy in
subgroups selected for history of food sensitivity or
atopic constitution [2]. A Dutch open pilot study in
which 40 children with ADHD followed a few foods
diet [23], resulted in a reduction of at least 50% in the
symptom scores on rating scales completed by par-
ents and teachers in 62% of the subjects. The present
randomised controlled trial study was designed to
assess the efficacy of a few foods diet in a group of
ADHD children unselected for affinity with dietary
interventions or the presence of physical problems.
This study has been registered as an Interna-
tional Standard Randomised Controlled Trial, number
ISRCTN47247160.
Methods
j Study population
Participants were selected from a consecutive series of
79 Dutch children who were referred to the ADHD
Research Centre between January and June 2006. Of
these children, 27 were enrolled in the trial (Fig. 1).
They were between 3.8 and 8.5 years old and they all
met the criteria as defined in the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) for ADHD Combined Type or Predomi-
nantly Hyperactive-Impulsive Type [1]. The following
79 children screened
for eligibility 
52 excluded:
43 not meeting inclusion criteria
9 refused to participate
27 randomised
15 assigned to intervention group 12 assigned to control group
2 dropped out:
1 child sick
1 withdrawn 
1 dropped out: withdrawn 
13 completed the trial 11 completed the trial
Fig. 1 Trial profile
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exclusion criteria were used: adopted or foster chil-
dren, co-existing neurological diseases, an IQ below
70, prematurity or dysmaturity, use of alcohol, or
smoking by mother during pregnancy [31], and
co-existence of other psychiatric disorders, except for
oppositional defiant disorder (ODD) and conduct
disorder (CD). The screening involved a systematic
and complete review of the symptoms and diagnostic
criteria of all DSM-IV axis I disorders occurring in
childhood. None of the children used psychotropic
medication.
Parents were given verbal and written information
about the study, and duly signed informed parental
consent forms were obtained before randomisation.
Children who were already on a diet had to cease this
diet at least 2 weeks before the start of the trial.
j Design and procedures
The efficacy of an elimination diet in children with
ADHD was tested by comparing outcomes in the
children randomly assigned to the intervention group
to the outcomes in those assigned to the waiting-list
(control) group. Subjects were randomly allocated to
one of the two groups by means of a sequence of
numbered cards in sealed unmarked envelopes that
were prepared by an independent paediatrician. Each
card contained a reference to the group to which the
child would be allocated, and for each allocation an
equal number of cards [21] was used. The envelopes
were picked and opened by the parents in the pres-
ence of the researcher, and treatment was then dis-
pensed in accordance to the allocation on the card.
There were three measurement points: at study
entrance (week 0), after the baseline diet (week 3) and
after the elimination diet or waiting period (week 9).
An overview of the time schedule regarding measure
points and rating scales is presented in Table 1.
After the first assessments all children started with
a 2-week baseline diet in which they adhered to their
normal diet, no foods were eliminated. During the
baseline diet the parents kept an extended diary in
order to enable an assessment of the child’s normal
diet, its behaviour and activities. After the baseline
diet and the second assessment, the intervention
group started with an individually composed elimi-
nation diet [15], which had to be followed for a period
of 5 weeks. The elimination diet consisted of rice,
turkey, lamb, vegetables, fruits, margarine, vegetable
oil, tea, pear juice and water [8, 23]. The control
group was placed on a waiting list and continued their
own, freely chosen diet. At the start of the trial the
parents of the control group were informed that they
could start with the elimination diet immediately after
the last assessment if they so wished.
Primary endpoints were the parent and teacher
ratings on the Abbreviated ten-item Conners Scale
(ACS) and the ADHD Rating Scale (ARS) before and
after the elimination diet or the waiting period. The
ACS [9], has often been used in ADHD treatment
studies [7, 8, 14, 23, 25]. It consists of ten items of
behaviour, focusing on overactivity, impulsivity and
inattention, and uses a four-point rating scale (0
never, 1 sometimes, 2 often, 3 always). The ARS is a
frequently used rating scale based on the DSM-IV
criteria for ADHD [21, 29]. The scores are divided in
three parts: the Number of ADHD criteria (18 in all),
the nine items regarding inattention and the
nine items regarding impulsivity and hyperactivity,
the latter both marked out on a four-point rating
scale [13].
Secondary endpoints were parent ratings on ODD
symptoms measured by a structured psychiatric
interview (SPI) based on the DSM-IV-criteria for
ODD.
The parents and teachers who filled in the ques-
tionnaires could not be blinded as they had to
supervise the food intake of the child and knew
whether the child was following an elimination diet.
j Statistical analysis
SPSS version 9.0 was used for all statistical analyses.
Data was analysed on an intention-to-treat basis, with
Table 1 Time table
Measure points Rating scales parents Rating scales teacher Intervention group Control group
Week 1 1 ACS-1, ARS-1 Start of baseline diet Start of baseline diet
Entrance trial
Week 2 Baseline diet Baseline diet
Week 3 2 ACS-2, ARS-2 ACS-2 Baseline diet ends Baseline diet ends
After baseline SPI ARS-2 Elimination diet starts Waiting list starts
Week 4–9 Elimination diet Waiting list
Week 9 3 ACS-3, ARS-3 ACS-3 Elimination diet ends Waiting list ends
At endpoint SPI ARS-3 Elimination diet starts (if desired)
ACS abbreviated conners scale, ARS ADHD rating scale, SPI structured psychiatric interview
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last observations carried forward in cases of missing
data. Descriptive parameters for indicating effect size
were % scale reduction and Cohen’s d. Effects were
tested at P < 0.05; all testing was two-tailed. Subjects
were defined as showing clinically significant
improvement (responders) if the difference between
measure point 3 (after the elimination diet) and
measure point 2 (after the baseline diet) was 50% or
more on both the ACS and the ARS. Data was ana-
lysed by Student’s t test and Fisher’s exact test.
Results
In sum 79 children were screened for eligibility, 43 of
these failed to meet the inclusion criteria, and 9
refused to participate. As a result 27 children entered
the study and were randomised to the intervention
group [15] or the control group [12]. The descriptive
characteristics of the subjects enrolled are presented
in Table 2. Of the 27 children, 3 (11%) were lost to
follow up: one child assigned to the control group
withdrew after randomisation, whilst two children
assigned to the intervention group dropped out, one
because of illness, the other because the parents
lacked motivation to stick to the diet (see Fig. 1). For
17 of the 27 children, teacher data was available, in
the other cases school contact at both Baseline and
Endpoint rating was not possible due to holidays or
teacher’s illness.
j Primary outcomes
Table 3 shows the parent ratings on the ACS, ARS and
the SPI for both the intervention group and the control
group (1) at the start of the trial, (2) after the baseline
diet, and (3) at the end of the trial. The mean scores at the
start of the trial and after the baseline diet was greater
than 22.7 points (ACS) and 13.7 points (ARS Number of
ADHD criteria, 18 at the most) in both the intervention
and the control groups. There was no significant dif-
ference in the scores of both measurement points. At
the end of the trial the mean scores in the intervention
Table 2 Descriptive characteristics of study participants at time of inclusion
Intervention
group N (%)
Control
group N (%)
Number of participants 15 12
Boys 12/15 (80.0%) 10/12 (83.3%)
Age (mean (SD)) 6.3 (1.6) 6.1 (1.7)
ADHD combined type 10/15 (66.7%) 8/12 (66.7%)
ADHD predominantly
hyperactive-impulsive type
5/15 (33.3%) 4/12 (33.3%)
Co-morbid ODD 12/15 (80.0%) 10/12 (83.3%)
On dietary restriction 0/15 (0%) 1/12 (8.3%)
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group showed a 62.6% improvement on the ACS and a
70.3% improvement on the ARS Number of ADHD
criteria (P < 0.001). In the waiting-list group the scores
increased by 4.4% (ACS) and decreased by 2.2% (ARS
Number of ADHD criteria). Children in the intervention
group showed a significantly greater decrease in
behaviour problems than children in the control group,
with a treatment effect—i.e. the difference in improve-
ment between the intervention and control group—of
17.6 (95% Confidence Interval (CI) 12.5–22.6, P < 0.001,
Student’s t test) on the ACS and 9.4 (95% CI 5.9–12.8,
P < 0.001) on the ARS Number of ADHD criteria. The
treatment effect on the ARS included both inattention
symptoms (mean difference 11.8, P < 0.001) and
hyperactivity/impulsivity symptoms (mean difference
14.1, P < 0.001). The effect size (Cohen’s d) was 2.8
(67.3% scale reduction) on the ACS and 2.1 (69.4% scale
reduction) on the ARS Number of ADHD criteria.
According to the parent ratings 11/13 children (85%) in
the intervention group who completed the study showed
an improvement of 50% or more, (mean difference on
the Number of ADHD criteria 11.2 (95% CI 9.0–13.5,
P < 0.001). None of the children in the control group
(0/11) showed an improvement of 50% or more (mean
difference on the Number of ADHD criteria 0.3 (95% CI
)0.4 to 0.9, P < 0.43).
Table 4 shows the teacher ratings on the ACS and the
ARS for both the intervention group and the control
group (1) after the baseline diet, and (2) at the end of the
trial. The parents’ conclusions in Table 3 were con-
firmed by the teachers. The treatment effect was 13.3
on the ACS (95% CI 7.5–19.1, P < 0.001) and 8.4 on the
ARS Number of ADHD criteria (95% CI 4.8–11.9,
P < 0.001), including both inattention symptoms (mean
difference 8.3, P < 0.011) and hyperactivity/impulsivity
symptoms (mean difference 12.8, P < 0.002). The effect
size (Cohen’s d) was 2.4 (64.3% scale reduction) on the
ACS and 2.5 (70.6% scale reduction) on the ARS Num-
ber of ADHD criteria.
According to the parent ratings, 11 out of the 15
children in the intervention group (73%) could be clas-
sified as responders, defined as showing behavioural
improvement of at least 50% on both the ACS and the
ARS. All responders did not meet the DSM-IV-criteria
for ADHD anymore. In the control group, none of the 12
children (0%) were classified as responders (two-tailed
Fisher’s exact test, P < 0.001). According to the teacher
ratings (N = 17) 7/10 children in the intervention group
were responders (70%), versus 0/7 children (0%) in the
control group (two-tailed Fisher’s exact test, P < 0.01)
j Secondary outcomes
At the entrance of the trial, 12/15 children in the
intervention group (80%) and 10/12 children in the Ta
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control group (83%) met the DSM-IV-criteria for
ODD according to the SPI (see Table 3). The mean
number of ODD-symptoms was 6.5 in the interven-
tion group (the DSM-IV-diagnostic criteria for ODD
are met if the child complies with four or more out of
eight symptoms) and 5.4 in the control group. At the
end of the trial, 4/15 children in the intervention
group (27%) and 10/12 children in the control group
(83%) still met the ODD-criteria, the mean number of
ODD-symptoms now being 2.9 in the intervention
group and 5.3 in the control group. The difference
between the measure points at the beginning and at
the end of the trial was 3.6 (95% CI 1.7–5.4, P < 0.001)
in the intervention group and 0.1 (95% CI )0.9 to 1.1,
P < 0.83) in the control group, with a mean difference
of 2.4 (95% CI 0.4–4.3, P < 0.02). The effect size
(Cohens’s d) was 1.1 (45.3% scale reduction).
Discussion
Our results show that a carefully supervised few foods
diet in young children with ADHD, followed for 5 weeks
at the most, can exhibit substantial changes in behav-
iour. Seventy percent of the children showed behav-
ioural improvements of 50% or more according to the
ratings of parents and teachers and did not meet the
DSM-IV-criteria for ADHD anymore. The results of this
randomised controlled study do not differ from the
results of equivalent studies [7, 8, 14, 17, 25, 26]. All
controlled trials on ADHD and foods using a few foods
diet show a more or less beneficial effect on the behav-
iour of the subjects. The extent of restriction of the
elimination diet seems important and may affect the
degree of the behavioural improvements: a diet
including too many foods may reduce the number of
responders [25]. Consequently, a diet excluding just one
or a limited number of foods, like sugar or additives,
would be of little benefit to children with ADHD [8, 10,
15]. Recent additive trials have shown that some degree
of hyperactivity, when exposed to artificial food colours
and benzoate preservatives, may be applied to all 3-year-
old children, not exclusively to hyperactive children [4,
20]. This might imply that there is a general adverse
effect of additives or preservatives on the behaviour of
all young children, with a small effect size (0.18).
As we wanted to investigate the influence of foods
on ADHD, we excluded children with potentially
predisposing environmental risk factors for ADHD,
like prematurity, dysmaturity and foetal exposure to
maternal alcohol or cigarettes [31]. Efforts were made
to obtain an unbiased sample, the children were not
preselected for affinity with dietary intervention.
At the entrance of the study, 22/27 children also
met the criteria for ODD, 80% of the children in the
intervention group and 83% of the children in the
control group. Co-existence of ODD is very common
in ADHD [31]. At the end of the trial, all children in
the control group still met the criteria, but in the
intervention group the number of children meeting
the ODD-criteria had diminished by 66%. We ex-
pected the children in the intervention group to show
deterioration of their ODD behaviour, opposing the
dietary restrictions which they surely would not like.
It appears as if the elimination diet triggers a sig-
nificant change in both ADHD-symptoms and ODD-
symptoms. This is important, as ADHD-children with
co-morbid ODD/CD are at risk for long-term malad-
justment [3]. It is tempting to speculate that the
appliance of an elimination diet in young children
might reduce this risk.
j Study limitations
This study is an open-label controlled trial, without
placebo. The elimination diet used in this study was
very restricted, only a few foods were allowed, thus
making it impossible to compose a reliable placebo
diet. The fact that even a small change in the diet of a
child, like removing additives, may have a beneficial
effect on the behaviour of children [4, 20], illustrates
the difficulties of constructing a placebo diet. Parents
and teachers were aware of the intervention, which is
a limitation that needs to be acknowledged. Although
open randomised controlled trials are commonly used
when blinding is difficult [6, 11, 24, 27, 28, 30, 33, 34],
we recommend replication of this trial with blinded
measurements by an independent observer [6]. Also
the incorporation in future studies of objective tests
of attentional performance and executive functioning
should be considered.
It is conceivable that the increased attention for the
child during the elimination diet contributes to
the behavioural improvements. In order to measure the
effects of increased attention during this trial, all parents
had to keep an extended diary during the baseline diet,
having to watch their child carefully. The second
assessment took place at the end of the baseline diet.
There were no significant differences between the scores
at the entrance of the trial and after baseline. Still the
placebo effects of expectation and intense caregiver
involvement have to be considered.
The adherence to a restricted elimination diet can
be considered as burdensome, dietary management is
difficult and puts a considerable strain on the family
[8], so this method will not be applicable to all chil-
dren with ADHD. Still dietary investigation can be an
option for some children, and parents who are
interested should be offered the possibility to follow a
few foods diet with their child, provided that a trained
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dietician is available to supervise the intervention
[15]. If the diet has a beneficial effect on the behav-
iour, challenge tests with specific foods should be
exhibited to identify the incriminated foods and to
make the diet more manageable. Further research
could focus on the follow up of dietary interventions
in children with ADHD and on the feasibility of long-
term dietary restrictions.
The mechanisms in which foods exerts its effects
remain unclear. Toxic, pharmacological, or immu-
nologic mechanisms could be involved and the
physiological effects of different foods may vary [8].
More research on this topic is needed.
In conclusion, this study confirms the results of
earlier studies [7, 8, 14, 17, 25, 26], that a strictly
supervised and restricted elimination diet can affect
the behaviour of some children with ADHD and may
be a valuable instrument in testing young children
with ADHD on whether dietary factors may contrib-
ute to the manifestation of the disorder.
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